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Introduction {#irv12372-sec-0005}
============

Seasonal influenza viruses typically circulate between November and March in the Northern Hemisphere and between April and September in the Southern Hemisphere.[1](#irv12372-bib-0001){ref-type="ref"}, [2](#irv12372-bib-0002){ref-type="ref"} While influenza surveillance data have been used to inform vaccination strategies in temperate regions, historically data from countries in the tropics and subtropics have been limited.[3](#irv12372-bib-0003){ref-type="ref"}, [4](#irv12372-bib-0004){ref-type="ref"} With the strengthening of influenza surveillance in recent years supported by the use of reverse transcription--polymerase chain reaction, more data on influenza activity in the tropics and subtropics are available, showing a complex seasonal pattern with year‐round circulation in some areas and biannual peaks in others.[4](#irv12372-bib-0004){ref-type="ref"} The more diffuse patterns of influenza activity further complicate vaccination recommendations, specifically timing of vaccination, for countries in the tropics.[5](#irv12372-bib-0005){ref-type="ref"} Recent surveillance data from tropical regions of Asia have revealed a seasonal pattern characterized by year‐round low‐level influenza virus circulation with peaks occurring during the monsoon (rainy) season.[6](#irv12372-bib-0006){ref-type="ref"} The distinct pattern has important implications for influenza vaccine timing in this region.[4](#irv12372-bib-0004){ref-type="ref"}, [6](#irv12372-bib-0006){ref-type="ref"}, [7](#irv12372-bib-0007){ref-type="ref"}

Availability of surveillance data for influenza subtype/lineage from tropical regions of Asia, together with recent efforts to introduce quadrivalent influenza vaccines, prompted us to undertake in‐depth analysis of data from nine countries around southern and southeastern Asia to further characterize influenza type‐ and subtype‐specific seasonality and associated latitude gradient in this region.

Methods {#irv12372-sec-0006}
=======

Study design {#irv12372-sec-0007}
------------

Monthly surveillance data from 2007 to 2013 (*N* = 1 586 757 specimens) collected as part of the World Health Organization\'s Global Influenza Surveillance and Response System (GISRS) were obtained directly from eight countries in the Asian region, while data for Japan were accessed from the FluNet server \[<http://www.who.int/influenza/gisrs_laboratory/flunet/en/>\] (Table [1](#irv12372-tbl-0001){ref-type="table-wrap"}). Nasopharyngeal and/or throat swabs from patients presenting with influenza‐like illness (ILI) or hospitalized with severe acute respiratory infection (SARI) at sentinel surveillance sites were tested for influenza viruses either by virus isolation in Madin--Darby canine kidney (MDCK) cells or by real‐time reverse transcription--polymerase chain reaction (RT‐PCR) using standard protocols [8](#irv12372-bib-0008){ref-type="ref"} and considered positive if detected by either method. Influenza virus typing and subtyping were carried out using United States Centers for Disease Control and Prevention (CDC) protocols.[9](#irv12372-bib-0009){ref-type="ref"} Influenza B lineage testing was carried out for a subset of influenza‐positive specimens and increased after 2009.

###### 

Specimens tested and influenza positivity results in the nine study countries of Asia

  Country/Regions                                  Total samples   Influenza A   Influenza B                                                                                                                                               
  ------------------------------------------------ --------------- ------------- ------------- --------- ------ ------------------------------------ ----------------- -------- ------ --------------------------------------------------- -----------------
  Japan[b](#irv12372-note-0002){ref-type="fn"}     NA              76 374                      66 373    86·9   December--March                      Winter            10 001   13·1   December--April                                     Winter
  North China                                      547 154         77 824        14·2          55 889    71·8   November--March                      Winter            21 935   28·2   December--March                                     Winter
  South China                                      820 595         141 771       17·3          102 612   72·4   July--September and January--March   Monsoon--Winter   39 159   27·6   December--April                                     Winter
  India                                            29 319          3471          11·8          2155      62·1   June--August                         Monsoon           1313     37·8   August--December                                    Monsoon--Winter
  Lao PDR[c](#irv12372-note-0003){ref-type="fn"}   5701            1026          18·0          684       66·7   September--December                  Monsoon           342      33·3   July--January                                       Monsoon--Winter
  Thailand                                         25 826          5276          20·4          3408      64·6   July--November                       Monsoon           1868     35·4   August--February                                    Monsoon--Winter
  Cambodia                                         13 346          2103          15·8          1226      58·3   July--October                        Monsoon           877      41·7   September--January                                  Monsoon--Winter
  Philippines                                      73 629          12 698        17·2          10 635    83·8   July--October                        Monsoon           2063     16·2   September--December                                 Monsoon--Winter
  Malaysia                                         11 285          805           7·1           577       71·7   --                                                     233      28·9   April--May, August--October                         Monsoon--Winter
  Singapore                                        59 902          14 750        24·6          12 310    83·5   May--June                            Monsoon           2440     16·5   January--February, April--May, November--December   Monsoon--Winter
  Total[d](#irv12372-note-0004){ref-type="fn"}     1 586 757       259 724       16·4          189 496   73·0   --                                                     70 230   27·0   --                                                  

Defined as 2 or more consecutive months with monthly proportion of annual positive samples above 8·3%.

Data from FluNet.

Data for 2008--2013.

Excluding data from Japan.

John Wiley & Sons, Ltd

Data analysis {#irv12372-sec-0008}
-------------

Data were analyzed by country, except for China which was analyzed by northern and southern China (Appendix [2](#irv12372-app-0002){ref-type="app"}: List of provinces). We used monthly instead of weekly surveillance data as we felt that it is more practicable for policy guidance for influenza seasonality and vaccination timing especially at the regional level. We calculated proportion of influenza A‐ and influenza B‐positive samples separately in a month out of total influenza A‐ and total B‐positive samples, respectively, in a given year to analyze the monthly pattern. This allowed us to adjust for inter‐ and intracountry variations in terms of samples tested and sample positivity. The epidemic period for each influenza type was defined as two or more consecutive months with monthly proportion of annual positive samples above 8·3% for that type, that is the average percentage of cases detected per month (100% divided by 12 months). The peak month was defined as the month with highest average proportion of annual positives. We plotted the seasonal patterns of areas/countries using Epi‐Map to identify the latitudinal gradient.

Ethical review {#irv12372-sec-0009}
--------------

The study used aggregated data from each country collected for influenza surveillance as part of FluNet.

Results {#irv12372-sec-0010}
=======

During 2007--2013, results from testing of 1 586 757 specimens were available for analysis from eight countries (data for Japan -- not available) (Table [1](#irv12372-tbl-0001){ref-type="table-wrap"}). A total of 336 098 influenza‐positive samples were detected including Japan (*n* = 76 734), northern China (*n* = 77 824), southern China (*n* = 141 771), India (*n* = 3471), Lao PDR (*n* = 1026), Thailand (*n* = 5276), Cambodia (*n* = 2103), the Philippines (*n* = 12 698), Malaysia (*n* = 805) and Singapore (*n* = 14 750). The proportion of specimens testing positive for influenza viruses ranged from 7 to 25%. Although influenza A viruses accounted for a larger proportion of all influenza‐positive specimens during most years, influenza B viruses accounted for \>50% of influenza positives in 2010--2011 and 2012--2013 (data not shown).

The study revealed three patterns of influenza A seasonality that coincided with the latitudinal position of countries (Figures [1](#irv12372-fig-0001){ref-type="fig"} and [2](#irv12372-fig-0002){ref-type="fig"}). First, areas lying above 30°N latitude (Japan and northern China) were characterized by influenza A epidemics during winter months of November--March. Second pattern was observed in areas between 10° and 30°N latitude (southern China, India, Thailand, Lao PDR, Cambodia and the Philippines) that have influenza A epidemics during monsoon months of June--December although some areas (southern China, India, Thailand) showed 3--8% of annual influenza A positives even during non‐epidemic months. Third pattern was seen in areas lying close to the equator approx. 0--10°N latitude (Malaysia and Singapore) displaying no specific seasonality in influenza A virus circulation (Figures [1](#irv12372-fig-0001){ref-type="fig"} and [2](#irv12372-fig-0002){ref-type="fig"}). In contrast, there were two patterns to influenza B circulation in this region: a distinct seasonality coinciding with influenza A circulation in areas lying north of 30°N latitude (Japan and northern China); while in areas south of 30° N (except Cambodia) year‐round circulation with 3--8% of annual influenza B positives during most months with less pronounced and lagged peaks after influenza A peaks occurring between September and February.

![Consensus seasonality of influenza A and B in the nine study countries of Asia (2007--2013 excluding 2009). Each panel graph is for each country/region, and bars denote mean of monthly type‐specific proportion of annual number of influenza type‐positive samples. The bluish‐gray bars indicate influenza A and orange bars indicate influenza B. The horizontal dashed line denotes threshold value of 8·3% of annual positive. Monthly pattern of influenza proportion positives in each year is shown by line graph; the data for 2009 were excluded because of the pandemic which did not follow the usual seasonality pattern.](IRV-10-176-g001){#irv12372-fig-0001}

![Influenza virus circulation patterns in the nine study countries of Asia, 2007--2013. Areas with winter peaks of influenza are indicated by green color, and areas with monsoon peaks of influenza are indicated by blue, and areas with year‐round circulation with no distinct peaks have been shaded yellow.](IRV-10-176-g002){#irv12372-fig-0002}

The predominant circulating influenza A subtype and B lineage varied by year. The predominant influenza A subtype was A/H1N1pdm09 during 2009--2011 and A/H3N2 in 2012, whereas both subtypes were codominant in 2013 (Figure [3](#irv12372-fig-0003){ref-type="fig"}). Similarly data on influenza B lineage revealed B/Yamagata‐lineage viruses predominated during 2007--2008, and B/Victoria‐lineage during 2009--2010 and cocirculation of both lineages during 2012. B/Yamagata‐lineage again became the predominant strain in 2013. Thus, both influenza B lineage viruses in varying proportions circulated in most years across most countries (Figure [3](#irv12372-fig-0003){ref-type="fig"}).

![Subtype variation in selected study countries in the Asian region (2007--2013). Each panel graph is for each country and influenza type, and stacked bars denote the circulating subtypes during the year.](IRV-10-176-g003){#irv12372-fig-0003}

Discussion {#irv12372-sec-0011}
==========

This study indicated that in the tropical regions of southern Asia, influenza A viruses cause seasonal epidemics typically during monsoon months, whereas influenza B viruses circulate year round with smaller peaks during the post‐monsoon months. In contrast, in the temperate region, both influenza A and B viruses peak during the winter months, similar to other countries in temperate regions of the Northern Hemisphere and Southern Hemisphere.[1](#irv12372-bib-0001){ref-type="ref"}, [5](#irv12372-bib-0005){ref-type="ref"} The subnational data from India and China revealed that areas at approximately ≥30°N latitude have winter peaks of both influenza A and B virus circulation, whereas areas in these countries that lie below \<30°N latitude, influenza A peaks occur primarily during the monsoon season with influenza B circulation year round with smaller peaks during post‐monsoon months.[10](#irv12372-bib-0010){ref-type="ref"}, [11](#irv12372-bib-0011){ref-type="ref"}, [12](#irv12372-bib-0012){ref-type="ref"}While reason for discrepant seasonality in circulation of influenza A and B viruses in tropical Asia is not clear, it is plausible that either environmental or other factors in tropical regions play a role in sustained circulation of influenza B viruses throughout the year. Additional high‐quality surveillance along with systematically collected data on climatic and environmental variables from tropical countries would allow further evaluation of relationship between these factors and influenza seasonality.[11](#irv12372-bib-0011){ref-type="ref"}, [13](#irv12372-bib-0013){ref-type="ref"}, [14](#irv12372-bib-0014){ref-type="ref"}

World Health Organization makes biannual recommendations for the composition of seasonal influenza vaccines for Northern Hemisphere and Southern Hemisphere.[15](#irv12372-bib-0015){ref-type="ref"} Until recently, the trivalent vaccine included influenza A(H1N1), A(H3N2), and B strains with only one of the two B lineages represented; however, a quadrivalent vaccine comprising of two each of influenza A and B lineages is being licensed in some countries. The data presented here showing cocirculation of both lineage of influenza B further lend support to possible use of quadrivalent vaccine in tropical Asian countries, if available.

We previously suggested that the most appropriate time for influenza vaccination in the tropical regions of southern and southeastern Asia would be during April--May prior to the monsoon season instead of October--November as is practiced in temperate regions of Northern Hemisphere,[6](#irv12372-bib-0006){ref-type="ref"} and similar recommendations can be made from current data. Even though round the year circulation of influenza B complicates the timing of vaccination in areas south of 30°N, the pre‐monsoon vaccination time should confer protection against influenza B peak season. However, the vaccine using Northern Hemisphere strain of the coming season will not be available in April--May, so countries may need to consider using the Southern Hemisphere strain which will have the most recent WHO‐recommended strains.

The data reported here have limitations; first, the surveillance systems in these countries differ in terms of population coverage and data collection methods. Additionally, we used monthly data, which precluded some of the statistical analysis possible for weekly data. Secondly, we used aggregated data for China and India both of which have vast latitudinal expanse, and the surveillance is relatively sparse in some parts of these countries and so may not have completely captured the complexity of influenza seasonality across the latitude gradient,[11](#irv12372-bib-0011){ref-type="ref"}, [12](#irv12372-bib-0012){ref-type="ref"} which we tried to partly address by analyzing China data by epidemiologically distinct northern and southern regions. Lastly, influenza B lineage data were restricted to some years and only subsamples in some countries in the region, further limiting our ability to in‐depth analysis. Nevertheless, we clearly show cocirculation of both influenza B lineages throughout the year in the tropical regions of Asia. Despite these limitations, we believe that our data provide first comprehensive analysis of both influenza type and subtype circulation across a wide latitude gradient in tropical Asia.

In summary, we provide evidence that while both influenza A and B viruses cause seasonal epidemics during the winter in temperate regions of Asia; in contrast, influenza A shows seasonal peak during monsoon with influenza B showing a lagged peak during the post‐monsoon/autumn season in tropical regions of Asia. Most importantly, cocirculation of both subtypes of influenza A and both lineages of influenza B was observed regardless of temperate or tropical climate.

Funding {#irv12372-sec-0012}
=======

This study used the available influenza surveillance data collected as part of the World Health Organization\'s Global Influenza Surveillance and Response System (GISRS). The surveillance in most of these countries were supported by U. S. Centers for Disease Control and Prevention (CDC) through cooperative agreements. No separate funding was received for this study.

Conflict of interest {#irv12372-sec-0013}
====================

None of the authors except PB have declared any conflict of interest. PB is on sabbatical leave from Pasteur Institute, Phnom Penh, Cambodia and currently employed by GSK Vaccines in Asia Pacific region. The opinions expressed by authors contributing to this article do not necessarily reflect the opinions of the U.S. Centers for Disease Control and Prevention, or the authors\' affiliated institutions.

 {#irv12372-sec-0014}

Wang Lijie^c^, Malinee Chittaganpitch^d^, Sunthareeya Waicharoen^d^, Kim A. Lindblade^f^ Vongphrachanh Phengta^e^; Darouny Phonekeo^e^, Andrew Corwin^f^, Sok Touch^g^, Philippe Buchy^h,i^, Raymond Lin^j^, Constance Low^j^, Chong Chee Kheong^k^, Apandi bin Yusof^l^, Amado Tandoc III^m^, Vito Roque Jr^n^, Vina Arguelles^n^, Fatimah S. Dawood^f^, Ann Moen^f^, Marc‐Alain Widdowson^f^, Nancy J. Cox^f^ and Renu B Lal^a^

^a^US CDC‐India, New Delhi, India

^b^National Institute of Virology, Pune, India

^c^Chinese National Influenza Center, Beijing, China

^d^National Institute of Health, Nonthaburi, Thailand

^e^Ministry of Health, Vientiane, Lao People\'s Democratic  Republic

^f^Centers for Disease Control and Prevention, Atlanta, GA,  USA

^g^Ministry of Health, Phnom Penh, Cambodia

^h^Pasteur Institute, Phnom Penh, Cambodia

^i^GSK Vaccines, R&D, Gateway West, Singapore

^j^Ministry of Health, Singapore, Singapore

^k^Ministry of Health, Kuala Lumpur, Malaysia

^l^Institute of Medical Research, Kuala Lumpur, Malaysia

^m^Research Institute for Tropical Medicine, Alabang, Philip pines

^n^Department of Health, Manila, Philippines

 {#irv12372-sec-0015}

Provinces in Northern China RegionProvinces in Southern China region1. Beijing1. Anhui2. Gansu2. Fujian3. Hebei3. Guangdong4. Henan4. Guangxi5. Heilongjiang5. Guizhou6. Jilin6. Hainan7. Liaoning7. Hubei8. Inner Mongolia8. Hunan9. Ningxia9. Jiangsu10. Qinghai10. Jiangxi11. Shandong11. Shanghai12. Shanxi12. Sichuan13. Shaanxi13. Yunnan14. Tianjin14. Zhejiang15. Tibet15. Chongqing16. Xinjiang

[^1]: The members in the Group of Asian Researchers on Influenza (GARI) are present in Appendix [1](#irv12372-app-0001){ref-type="app"}.
